The Current Ratio as of December 2025 (TTM) for Cutia Therapeutics (2487.HK) is 3.16

According to Cutia Therapeutics’s latest financial reports and current stock price. The company's current Current Ratio is 3.16. This represents a change of -26.32% compared to the average of 4.29 of the last 4 quarters.

Cutia Therapeutics (2487.HK) Historical Current Ratio (quarterly & annually)

How has 2487.HK Current Ratio performed in the past?

The mean historical Current Ratio of Cutia Therapeutics over the last ten years is 24.13. The current 3.16 Current Ratio has changed 1.21% with respect to the historical average. Over the past ten years (40 quarters), 2487.HK's Current Ratio was at its highest in in the December 2022 quarter at 14.80. The Current Ratio was at its lowest in in the June 2022 quarter at 0.

Cutia Therapeutics (2487.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cutia Therapeutics Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cutia Therapeutics (2487.HK) Average Current Ratio

How has 2487.HK Current Ratio performed in the past?

The current Current Ratio of Cutia Therapeutics (2487.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cutia Therapeutics (2487.HK) Current Ratio vs. Peers

How is 2487.HK’s Current Ratio compared to its peers?

Cutia Therapeutics’s Current Ratio is less than HighTide Therapeutics Inc (3.44), greater than Frontage Holdings Corporation (1.24), greater than SinoMab BioScience Limited (0.87), greater than Clover Biopharmaceuticals, Ltd. (0.26), greater than Mabpharm Limited (1.07), less than Zhaoke Ophthalmology Limited (4.40), less than Shanghai Bio-heart Biological Technology Co., Ltd. (12.65), greater than JW (Cayman) Therapeutics Co. Ltd (1.59), greater than Jiangsu Recbio Technology Co., Ltd. (0.32), greater than Immunotech Biopharm Ltd (0.08),

Build a custom stock screener for Cutia Therapeutics (2487.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cutia Therapeutics using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cutia Therapeutics (2487.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cutia Therapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.